Related Experiment Video
Updated: Oct 29, 2025

07:54
Applying Stereotactic Injection Technique to Study Genetic Effects on Animal Behaviors
Published on: May 10, 2015
14.4K
CGRP overexpression does not alter depression-like behavior in mice.
Narumi Hashikawa-Hobara1, Ami Otsuka1, Chihiro Okujima1
1Department of Life Science, Okayama University of Science, Okayama, Japan.
Peerj
|July 12, 2021
Summary
Calcitonin gene-related peptide (CGRP) overexpression in mice did not initially cause depression but led to depressive-like behaviors after stress. This indicates normal stress sensitivity and down-regulated Akt/mTOR pathways.
Area of Science:
- Neuroscience
- Molecular Biology
- Behavioral Science
Background:
- Calcitonin gene-related peptide (CGRP) is a vasodilator involved in pain and inflammation, notably studied in migraines.
- The role of CGRP overexpression in depressive-like behaviors is not well understood.
Purpose of the Study:
- To investigate the effects of CGRP overexpression on depressive-like behaviors in mice.
- To analyze the impact of stress on CGRP-overexpressing mice and relevant molecular pathways.
Main Methods:
- Behavioral tests (social interaction, open field, sucrose preference) were used to assess stress and depressive-like behaviors in CGRP transgenic (Tg) mice.
- mRNA and protein analyses were conducted on hippocampal brain-derived neurotrophic factor (BDNF), phosphorylated Akt, mTOR, and p70S6K.
Main Results:
- CGRP Tg mice initially showed stress resistance with increased BDNF mRNA but normal social interaction.
- After 15-day social defeat stress, CGRP Tg mice exhibited depressive-like phenotypes, including social avoidance and reduced sucrose preference.
- Stress exposure decreased hippocampal p-Akt, p-mTOR, and p-p70S6K levels in CGRP Tg mice, while BDNF levels remained unchanged.
Conclusions:
- CGRP-overexpressing mice demonstrate normal sensitivity to social defeat stress.
- Stress induces depressive-like behaviors in CGRP Tg mice, linked to down-regulation of the hippocampal Akt/mTOR/p70S6K signaling pathways.

